{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://www.entherapharmaceuticals.com/#organization",
      "name": "Enthera – First-in-class therapeutics for auto-immune disorders",
      "url": "https://www.entherapharmaceuticals.com/",
      "description": "Enthera – First-in-class therapeutics for auto-immune disorders Privacy Policy Corporate Documents Whistleblowing About Us At a Glance Management Team Team Board of Directors Investors Our Science Pipeline Collaborations Media Centre Press Releases Events Publications Interactive Media In The News Careers Contact Us Menu Menu First-in-class therapeutics for autoimmune disorders Developing the first disease-modifying treatment for severe autoimmune disorders. Learn more About Us We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable au"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/enthera-and-8211-first-in-class-therapeutics-for-auto-immune-disorders#asg",
      "name": "Enthera – First-in-class therapeutics for auto-immune disorders ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/enthera-and-8211-first-in-class-therapeutics-for-auto-immune-disorders",
      "isPartOf": {
        "@id": "https://www.entherapharmaceuticals.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}